Cosmos Health Inc.: Q4 2026 U.S. revenue expected to reach $15,000,000

What happened

• On Oct 19, 2026, Cosmos Health Inc. issued a press release announcing certain preliminary and expected results for the Company’s fourth fiscal quarter ending Dec 31, 2026, including that Q4 2026 U.S. revenue is expected to reach $15,000,000, with gross profit of $10,500,000, and that active U.S. subscriptions increased 42% from 6,287 to 8,940 in five days. A copy of the press release is attached as Exhibit 99.1.
• The filing also includes a CEO letter dated Oct 20, 2026, attached as Exhibit 99.2, and states those exhibits are furnished under Regulation FD and are not “filed” for purposes of Section 18 of the Exchange Act nor incorporated by reference.

Key details

• Q4 2026 U.S. revenue expected to reach $15,000,000; gross profit expected to be $10,500,000.
• Active U.S. subscriptions rose 42%, from 6,287 to 8,940, measured over a five-day period.
• Press release dated Oct 19, 2026 (Exhibit 99.1) and CEO letter dated Oct 20, 2026 (Exhibit 99.2) are furnished; the filing states those exhibits are not deemed “filed” under Section 18 and are not incorporated by reference.

Why it may matter

• The 8-K reports Item 2.02 (results of operations and financial condition) covering preliminary and expected Q4 2026 U.S. results, and Item 7.01 (Regulation FD disclosure) covering the furnishing and regulatory treatment of the attached materials. This filing does not show why the insider traded or why the company acted.